Financials
- Market Capitalization 43.12 M
- Employee 39
- Founded 2015
- CEO Denise Scots-Knight
- Website www.mereobiopharma.com
- Headquarter United Kingdom
- FIGI BBG00KFWZC67
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-10.59
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4293 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.14 USD | +1.90% | +1.90% | +2.39% | -46.23% | 45.02 M USD | ||
| 4301 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.16 USD | -0.85% | -5.69% | -3.33% | -19.44% | 43.82 M USD | ||
| 4323 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.79 USD | -3.24% | -10.05% | -9.60% | -81.43% | 40.60 M USD | ||
| 4331 | CRVO CervoMed Inc. - Common Stock | 2.64 USD | +2.72% | -0.38% | -1.86% | -75.42% | 39.91 M USD |